• 13
  • February
    2012

On February 3, 2012, Defendants in Fecho v. Eli Lilly filed a Motion for Reconsideration. The Motion asked Judge Marianne Bowler of the United States District Court of Massachusetts to reconsider and reverse her prior decision denying their Daubert motion and ordering the parties to mediate. Defendants' defeated Daubert motion aimed to exclude the Plaintiffs' experts. The Motion for Reconsideration was accompanied by a 50-page Findings of Facts and Conclusions of Law and submitted by fourteen drug manufacturers, including Eli Lilly Company and Bristol-Myers Squibb.

Today, Judge Bowler denied the Defendants' Motion for Reconsideration from the bench sua sponte, which means without prompting from the Plaintiffs. Judge Bowler has further scheduled to oversee mediation planning and organization between the parties on February 29, 2012.

If you are a DES daughter who contracted breast cancer, please contact our DES attorneys. We will help you evaluate whether you have an actionable case against DES drug manufacturers. Meanwhile, DES daughters should be diligent about routine breast exam screening and the avoidance of HRTs.